(Q35017527)

5 August 2017

title

Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment (English)

1 reference

5 August 2017

1 reference

Gianpiero Manes

1

1 reference

5 August 2017

Antonella Menchise

series ordinal

2

1 reference

5 August 2017

Claudio de Nucci

series ordinal

3

1 reference

5 August 2017

Antonio Balzano

series ordinal

4

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

5 August 2017

1 reference

5 August 2017

volume

326

1 reference

5 August 2017

issue

7399

1 reference

5 August 2017

page(s)

1118

1 reference

Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=156019

Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=156019

A prospective randomised trial of a "test and treat" policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=156019

The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=156019

The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=156019

Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=156019

Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=156019

Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=156019

Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=156019

Acute treatment of reflux oesophagitis: a multicentre trial to compare 150 mg ranitidine b.d. with 300 mg ranitidine q.d.s

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=156019

Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=156019

Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=156019

Endoscopy in the evaluation of dyspepsia. Health and Public Policy Committee, American College of Physicians

25 October 2018

1 reference

12 December 2020

Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia

1 reference

12 December 2020

PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI

1 reference

12 December 2020

Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study

1 reference

12 December 2020

Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia

1 reference

12 December 2020

Alternative management strategies for patients with suspected peptic ulcer disease

1 reference

12 December 2020

Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis

1 reference

12 December 2020

Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group

1 reference

12 December 2020

Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial

1 reference

12 December 2020

High prevalence of reflux symptoms in duodenal ulcer patients who develop gastro-oesophageal reflux disease after curing Helicobacter pylori infection

1 reference

12 December 2020

Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia

1 reference

12 December 2020

Helicobacter pylori infection, pattern of gastritis, and symptoms in erosive and nonerosive gastroesophageal reflux disease

1 reference

12 December 2020

Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease

1 reference

12 December 2020

10.1136/BMJ.326.7399.1118

Identifiers

DOI

1 reference

5 August 2017

1 reference

5 August 2017

1 reference